Skip to main content
Log in

Impact of 144 weeks of laronidase therapy on body functions, endurance and general well-being in a Hurler–Scheie patient

  • Short Report
  • Published:
Journal of Inherited Metabolic Disease

Summary

The quality of life of a Hurler–Scheie patient who experienced improvement in several organ functions and regained mobility after 144 weeks of laronidase enzyme replacement therapy is described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. L. Soutar.

Additional information

Communicating editor: Douglas Brooks

Electronic supplementary material

10545_2006_ESM_329.pdf

Impact of 144 weeks of laronidase therapy on body functions, endurance and general well-being in a Hurler–Scheie patient

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soutar, R.L., Mercer, J. & Wraith, J.E. Impact of 144 weeks of laronidase therapy on body functions, endurance and general well-being in a Hurler–Scheie patient. J Inherit Metab Dis 29, 590 (2006). https://doi.org/10.1007/s10545-006-0329-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-006-0329-5

Keywords

Navigation